These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9280126)

  • 1. HLA-B27 transgenic rats: animal model of human HLA-B27-associated disorders.
    O'Neill TP
    Toxicol Pathol; 1997; 25(4):407-8. PubMed ID: 9280126
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA-B27 transgenic rats model.
    Breban M
    Ann Med Interne (Paris); 1998 Apr; 149(3):139-41. PubMed ID: 11490535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response.
    Turner MJ; Sowders DP; DeLay ML; Mohapatra R; Bai S; Smith JA; Brandewie JR; Taurog JD; Colbert RA
    J Immunol; 2005 Aug; 175(4):2438-48. PubMed ID: 16081815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis in HLA-B27 transgenic animals.
    Taurog JD
    Am J Med Sci; 1998 Oct; 316(4):250-6. PubMed ID: 9766486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects in the pathogenesis of Bechterew disease].
    Märker-Hermann E; Sucké B; Meyer zum Büschenfelde KH
    Z Rheumatol; 1996; 55(1):4-18. PubMed ID: 8868146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors.
    Kollnberger S; Bird LA; Roddis M; Hacquard-Bouder C; Kubagawa H; Bodmer HC; Breban M; McMichael AJ; Bowness P
    J Immunol; 2004 Aug; 173(3):1699-710. PubMed ID: 15265899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective dendritic cell (DC) function in a HLA-B27 transgenic rat model of spondyloarthropathy (SpA).
    Stagg AJ; Breban M; Hammer RE; Knight SC; Taurog JD
    Adv Exp Med Biol; 1995; 378():557-9. PubMed ID: 8526141
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies.
    Khare SD; Luthra HS; David CS
    J Exp Med; 1995 Oct; 182(4):1153-8. PubMed ID: 7561688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression.
    Taurog JD; Maika SD; Simmons WA; Breban M; Hammer RE
    J Immunol; 1993 May; 150(9):4168-78. PubMed ID: 8473755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ankylosing spondylitis, HLA B27, and beyond.
    Nuki G
    Lancet; 1998 Mar; 351(9105):767-9. PubMed ID: 9519942
    [No Abstract]   [Full Text] [Related]  

  • 11. High prevalence of colorectal cancer in HLA-B27 transgenic F344 rats with chronic inflammatory bowel disease.
    Hammer RE; Richardson JA; Simmons WA; White AL; Breban M; Taurog JD
    J Investig Med; 1995 Jun; 43(3):262-8. PubMed ID: 7614072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mystery of HLA-B27 and disease.
    David CS
    Immunogenetics; 1997; 46(1):73-7. PubMed ID: 9148791
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental spondyloarthropathy in HLA-B27 transgenic rats.
    Taurog JD; Hammer RE
    Clin Rheumatol; 1996 Jan; 15 Suppl 1():22-7. PubMed ID: 8835497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of murine recombinant interleukin-10 on the inflammatory disease of rats transgenic for HLA-B27 and human beta 2-microglobulin.
    Bertrand V; Quéré S; Guimbaud R; Sogni P; Chauvelot-Moachon L; Tulliez M; Lamarque D; Charreire J; Giroud JP; Couturier D; Chaussade S; Breban M
    Eur Cytokine Netw; 1998 Jun; 9(2):161-70. PubMed ID: 9681392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
    Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
    Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8.
    Taurog JD; Dorris ML; Satumtira N; Tran TM; Sharma R; Dressel R; van den Brandt J; Reichardt HM
    Arthritis Rheum; 2009 Jul; 60(7):1977-84. PubMed ID: 19565478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment.
    Breban M; Hammer RE; Richardson JA; Taurog JD
    J Exp Med; 1993 Nov; 178(5):1607-16. PubMed ID: 8228809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenetic role of HLA-B27 and its subtypes.
    Khan MA; Mathieu A; Sorrentino R; Akkoc N
    Autoimmun Rev; 2007 Jan; 6(3):183-9. PubMed ID: 17289555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats.
    Tran TM; Dorris ML; Satumtira N; Richardson JA; Hammer RE; Shang J; Taurog JD
    Arthritis Rheum; 2006 Apr; 54(4):1317-27. PubMed ID: 16575857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27 and free HLA class I heavy chains in ankylosing spondylitis.
    Cauli A; Dessole G; Mathieu A
    J Rheumatol; 2003 May; 30(5):1120; author reply 1120-1. PubMed ID: 12734922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.